Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,248 total articles
BK Technologies (BKTI) is a small-cap specialist in two-way radio systems that, by pushing higher-margin software and services into its product mix, can justify a meaningful multiple expansion. The business already shows strong profitability (ROE ~30%), solid free cash flow ($18.4M), and recurring government order activity. This trade idea lays out…
Canadian Natural Resources (CNQ) combines low breakeven production, a history of aggressive dividend growth, and vertical integration that insulates margins. At a $102.7B market cap and a PE of ~13, the stock looks reasonably valued given current oil price dynamics. This trade idea recommends a long position at the market price with a defined stop …
Arm’s move from pure IP licensor to designing and selling its own AGI CPU, combined with a market shift toward agentic AI workloads that value power efficiency, sets up a plausible multi-quarter revenue rerating. We lay out an actionable long trade with entry, stop and target, and explain catalysts, valuation context and what could derail the thesi…
Greenwich LifeSciences (GLSI) has delivered consistent positive signals from its FLAMINGO-01 Phase III program: strong open-label immune responses, an ~80% preliminary recurrence reduction in the non-HLA-A*02 arm, expanded manufacturing and site activation, and new patent claims that could double the addressable market. With a tight float, modest m…
Viking Holdings trades at $71.49 with a $31.9B market cap, strong recent momentum, and a business model that consistently captures premium pricing. This trade targets a move back toward the $81 area while keeping downside contained with a precise stop. Technicals and short-interest dynamics make this a tradable swing with an asymmetric reward profi…
Apple's measured approach to AI - leveraging on-device models, developer tools, and its distribution power - is producing outsized revenue leverage without the heavy capex stampede that burdens peers. Strong FCF, double-digit services growth and bullish technical momentum create a pragmatic entry for a long trade: entry $252.00, stop $240.00, targe…
<p>Nvidia's leadership in GPU compute and software stack continues to reshape the economics of large-scale AI deployments. This trade idea proposes a mid-term long on NVDA to capture continued adoption and earnings upside as customers optimize models for Nvidia hardware. The plan includes a clear entry, stop, and target and explains the fundamental…
Cipher Digital has pivoted from pure-play Bitcoin mining to selling high-performance compute capacity to hyperscalers and cloud partners. With a $5.56B market cap, long-term deals with Amazon and Google-backed partners, and a $2.0B senior secured note financing, the stock offers asymmetric upside if AI capacity demand keeps rising — but the company…
Meren Energy presents a pragmatic trade: rising energy prices increase near-term revenue visibility, but the business sits at a critical execution and balance-sheet hinge. For disciplined traders, a structured long with a tight stop and clear targets offers asymmetric reward if commodity tailwinds persist and operational execution stabilizes.
Citigroup looks attractively priced relative to its historical multiple and peers, with P/E in the mid-teens, a $200B+ market cap, and multiple near-term catalysts (Q1 earnings, deal flow from large IPOs) that can reaccelerate revenues. This trade targets a run toward the prior 52-week high while keeping a disciplined stop below $109.
Sumitomo Mitsui Financial Group looks positioned for an earnings-quality re-rating as management leans into higher ROE targets and shareholder returns. The stock trades at a reasonable P/E of 13.6 and a PB of 1.31 with a 2.19% dividend yield. We recommend a mid-term long trade: entry $20.35, stop $19.00, target $24.00 (primary, 45 trading days) wit…
Nvidia sits at the center of a new agentic-AI macroeconomy. Its combination of data-center GPUs, networking, software stacks and enterprise AI services makes it the default infrastructure provider for autonomous, agentic workloads. Valuation is rich but supported by outsized free cash flow, razor-thin leverage and high returns on capital. This trad…
UnitedHealth is getting a clear tailwind from a stronger-than-expected Medicare Advantage rate decision and ongoing Optum margin initiatives. The company already converts large free cash flow and trades at reasonable multiples for a diversified health-services platform. This trade targets a tactical long aiming to capture margin re-rating into upco…
Tesla pulled back into the low $300s after an 11% one-day drop to $341.43. Fundamentals are mixed - revenue has softened and margins compressed, yet Tesla still produces positive free cash flow ($6.22B) and carries little net debt (debt/equity 0.10). Technically the stock is oversold (RSI 33) and trading well below its 50-day ($395) and 200-day ave…
Black Rock Coffee Bar (BRCB) is growing its company-owned, drive-thru-focused footprint across core Western U.S. markets while trading well below its 52-week high. The combination of accelerating store openings, a relatively tight float, and a market cap of roughly $669M supports a long-biased trade. Technicals are constructive for adding on weakne…
CMS's surprise bump to 2027 Medicare Advantage rates materially improves UnitedHealth's revenue outlook. With a reasonable valuation, strong cash flow and technical momentum, I recommend a mid-term long trade: entry $310.80, target $360.00, stop $292.00 (45 trading days). The plan assumes UnitedHealth captures a meaningful share of the $13B industr…
FuboTV (FUBO) has spent the last several months carving a low near $8.31 and has since rallied into the low $12s. With a compact float, heavy short interest and a market cap that looks inexpensive on sales and enterprise-value metrics, there’s a tactical long setup here for traders willing to accept elevated risk. This trade targets a mid-term reco…
Organogenesis announced on 04/06/2026 that its randomized controlled trial of PuraPly AM met the 12‑week wound closure primary endpoint. At a market cap near $295M and an EV of $245M, the shares look attractively priced given the binary clinical overhang is now reduced. This is a tactical long for a mid‑term rebound with a clearly defined entry at …
Rambus is uniquely positioned to benefit from an acute AI memory bottleneck thanks to HBM4 and DDR5 interface products. The stock has pulled back from its 52-week high; with no debt, $1.52B in cash and growing FCF, RMBS is an attractive leveraged swing candidate. This trade lays out a precise entry at $91.10, a $120 target and an $80 stop for a lon…
Blackstone (BX) offers a constructive risk/reward over the next 45 trading days: a $112.63 entry captures a 4.22% yield, attractive free cash flow and an EV/EBITDA of ~12 while pricing in private-credit angst. This trade targets a recovery to $140 with a $103 stop, acknowledging the real possibility of continued outflows or credit stress.
Lamb Weston beat Q3 FY2026 top-line but traded down on margin pressure and one-off ERP headaches. With input costs expected to ease in 2027 and a $250M cost-savings program in flight, we think margins can recover materially. The stock trades at a reasonable EV/EBITDA of 8.3 and yields ~3.7%, offering a cushion while earnings normalize. Upgrade to B…
HEICO (HEI) is seeing near-term pressure from geopolitical uncertainty, but its FAA-approved aftermarket parts franchise, strong cash generation, and a defensive balance sheet make a disciplined long trade attractive. Valuation has come in from the highs and technicals show a shallow oversold setup. Enter on weakness, size modestly, and use a clear…
ADMA Biologics plunged after a short-seller report alleged channel stuffing and triggered multiple law-firm investigations. The market sold first and asked questions later. ADMA's margins, liquidity and positive free cash flow argue the company can absorb reputational damage and restore normalized multiple if allegations don't lead to material rest…
A constructive read of the market reaction: Amgen's favorable TED data reset expectations across the field and knocked down Viridian shares. That weakness, combined with heavy oversold technicals, manageable balance-sheet metrics and a catalyst calendar, makes VRDN an asymmetric long for patient, catalyst-aware traders. Trade plan included with ent…
TAL Education shows tangible operational momentum: fiscal Q3 2025 revenue grew 62.4% and management has been investing in AI-powered learning tools and devices that can drive higher average revenue per student. At a market cap of about $6.8B and a P/E of ~23, the stock looks like a pragmatic swing trade as the market digests growth re-acceleration …
